Recent insider trading activity from HELLUMS RHONDA LYNETTE, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Silence Therapeutics plc | $SLN | HELLUMS RHONDA LYNETTE | Chief Financial Officer | A | Employee Share Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 141,701,848 | 9999.99% | 0.26% |
| Jan. 2, 2025 | Silence Therapeutics plc | $SLN | HELLUMS RHONDA LYNETTE | Chief Financial Officer | A | Employee Share Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 138,752,224 | 9999.99% | 0.27% |